Jiuzhitang Co., Ltd. (SHE:000989)

China flag China · Delayed Price · Currency is CNY
7.90
+0.08 (1.02%)
Jun 9, 2026, 3:04 PM CST
Market Cap6.69B -2.7%
Revenue (ttm)2.40B +14.3%
Net Income271.01M +44.0%
EPS0.32 +44.3%
Shares Out 846.28M
PE Ratio24.67
Forward PEn/a
Dividend0.30 (3.84%)
Ex-Dividend DateMay 14, 2026
Volume6,324,314
Open7.92
Previous Close7.82
Day's Range7.80 - 7.97
52-Week Range7.76 - 13.30
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateAug 19, 2026

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription dru... [Read more]

Sector Healthcare
Founded 1999
Employees 3,674
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000989
Full Company Profile

Financial Performance

In 2025, Jiuzhitang's revenue was 2.23 billion, a decrease of -5.99% compared to the previous year's 2.37 billion. Earnings were 222.60 million, an increase of 2.96%.

Financial Statements